Improving motor function in ALS using spinal cord stimulation techniques

Who could benefit from this research

What this research studies

This research investigates the use of transcutaneous spinal cord stimulation (TSCS) combined with transcranial magnetic stimulation (TMS) to enhance motor function in patients with amyotrophic lateral sclerosis (ALS). By applying these stimulation techniques, the study aims to activate damaged neural circuits in the spinal cord, potentially improving muscle control and overall motor function. The approach focuses on increasing neural plasticity, which may help strengthen voluntary motor output and prepare weakened circuits for better responses to exercise. The research is particularly relevant for veterans, as ALS is more prevalent in this population.

Why it matters

Where this research is happening

• James J Peters VA Medical Center
  Bronx, United States Active

Researchers

• Principal investigator: Harel, Noam Y. — James J Peters VA Medical Center
• Study coordinator: Harel, Noam Y.

Related research

Other NIH-funded projects on the same topics.

• Investigating how DNA damage and repair mechanisms are altered in ALS and frontotemporal dementia.

  This study is looking at how problems with DNA repair might contribute to conditions like ALS and frontotemporal dementia, and it’s testing ways to fix these issues in cells from patients to help develop new treatments.

  NIH research Methodist Hospital Research Institute · Houston, United States · NIH-9980670

• Understanding how work exposures and genes influence ALS risk

  A study is building a long-term group of people at higher risk for ALS to see how their jobs, exposures at work, and genes together affect if and when the disease might develop.

  NIH research University of Michigan at Ann Arbor · Ann Arbor, United States · NIH-11631673

• NUZ-001: a treatment option for ALS to protect nerve cells

  A small molecule called NUZ-001 is being tested to help people with ALS by improving cell systems that keep proteins balanced and prevent harmful protein clumps.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11564156

• Alpha5 integrin's role in ALS: how a cell switch worsens disease

  Aims to understand how a specific protein called alpha5 integrin in immune cells affects ALS progression and whether blocking it can help extend life.

  NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11540166

• C9orf72 ALS/FTD Prevent: prepping for future treatment

  This grant aims to get ready for a preventive treatment for people who carry the C9orf72 genetic change that can lead to ALS or frontotemporal dementia.

  NIH research University of Miami School of Medicine · Coral Gables, United States · NIH-11431628

• Air pollutants and ALS: mapping environmental links to motor neuron disease

  This NIH grant explores whether different air pollutants are linked to the development of ALS and uses a large U.S. data set to look for environmental risk factors.

  NIH research Washington University · Saint Louis, United States · NIH-11423391

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.